kLZSSUuwGQporAy1Eymb

SPPI Affirms Strong Patent Protection for FUSILEV

  • 0
  • 0

Spectrum Pharmaceuticals Incorporated - symbol SPPI - reported that the FDA has granted FUSILEV (levoleucovorin) “Orphan Drug” exclusivity for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer

11 Dec 2011

46 Visualizações

fusilev, levoleucovorin, sppi, usfda

Estatísticas do vídeo

Mostrar:

Comentários

Vídeos em Destaque